Skip to main content
NIH funding notice PAR-18-846

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)

Closed on June 25, 2021.

Posted
June 29, 2018
Close date
June 25, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $456,322 in first-year total cost, median $228,161.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 CVRS-H (50)]2

Most frequent institutions

  1. NEW YORK UNIVERSITY1
  2. WEST VIRGINIA UNIVERSITY1
Competing awards under PAR-18-846 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Genotoxic and mutagenic effects of combinations of e-cigarettes and tobacco carcinogens in mouse oral tissues1R21DE029711-01A1GUTTENPLAN, JOSEPH BNEW YORK UNIVERSITY, NY$228,322ZRG1
2020Effects of electronic cigarette wattage setting on vascular harm1R21ES033026-01CHANTLER, PAUL DOLFERT, I. MARKWEST VIRGINIA UNIVERSITY, WV$228,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.